Insmed (INSM) Change in Cash (2010 - 2026)
Insmed (INSM) posted Change in Cash of -$37.4 million for Q2 2026, down 152.16% on a QoQ basis from $71.7 million in Q1 2026, and down 104.25% year-over-year from $881.1 million in Q2 2025.
Analysis
Insmed (INSM) Change in Cash (2010 - 2026) Analysis & Trends
Insmed has reported Change in Cash for 17 years, with the latest figure at -$37.4 million in Q2 2026.
- On a quarterly basis, Change in Cash fell 104.25% year-over-year to -$37.4 million in Q2 2026; TTM through Jun 2026 was -$739.6 million, a 2070.84% decrease from a year earlier, with the FY2025 full-year figure at -$44.6 million, down 161.36% from the prior year.
- Change in Cash was -$37.4 million for Q2 2026 at Insmed, down from $71.7 million in the prior quarter.
- The five-year high for Change in Cash was $881.1 million in Q2 2025, with the low at -$949.6 million in Q3 2025.
- Average Change in Cash over 5 years is -$9.6 million, with a median of -$21.1 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Change in Cash slumped 8603.74% in 2023, then jumped 2074.66% in 2024.
- Over 5 years, Change in Cash stood at $659.4 million in 2022, then tumbled by 100.72% to -$4.7 million in 2023, then surged by 2074.66% to $93.6 million in 2024, then jumped by 87.74% to $175.7 million in 2025, then plunged by 121.3% to -$37.4 million in 2026.
- The last three Change in Cash figures came in at -$37.4 million (Q2 2026), $71.7 million (Q1 2026), and $175.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -37.42 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | -230.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.42 Mn |
| Mar 31, 2026 | 71.74 Mn |
| Dec 31, 2025 | 175.68 Mn |
| Sep 30, 2025 | -949.56 Mn |
| Jun 30, 2025 | 881.08 Mn |
| Mar 31, 2025 | -151.78 Mn |
| Dec 31, 2024 | 93.58 Mn |
| Sep 30, 2024 | -785.35 Mn |
| Jun 30, 2024 | 651.07 Mn |
| Mar 31, 2024 | 113.36 Mn |
| Dec 31, 2023 | -4.74 Mn |
| Sep 30, 2023 | -125.77 Mn |
| Jun 30, 2023 | -356.03 Mn |
| Mar 31, 2023 | -105.13 Mn |
| Dec 31, 2022 | 659.40 Mn |
| Sep 30, 2022 | -1.45 Mn |
| Jun 30, 2022 | -99.63 Mn |
| Mar 31, 2022 | -201.08 Mn |
| Dec 31, 2021 | -129.77 Mn |
| Sep 30, 2021 | -81.77 Mn |